Evidence That Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein-1 (MSP-119) Can Play a Protective Role against Blood-Stage Plasmodium falciparum Infection in Individuals in a Malaria Endemic Area of Africa
- 1 July 2004
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 173 (1) , 666-672
Abstract
The C-terminal 19-kDa fragment of Plasmodium falciparum merozoite surface protein-1 (MSP-119) is a target of protective Abs against blood-stage infection and a leading candidate for inclusion in a human malaria vaccine. However, the precise role, relative importance, and mechanism of action of Abs that target this protein remain unclear. To examine the potential protective role of Abs to MSP-119 in individuals naturally exposed to malaria, we conducted a treatment time to infection study over a 10-wk period in 76 residents of a highland area of western Kenya during a malaria epidemic. These semi-immune individuals were not all equally susceptible to reinfection with P. falciparum following drug cure. Using a new neutralization assay based on transgenic P. falciparum expressing the P. chabaudi MSP-119 orthologue, individuals with high-level MSP-119-specific invasion-inhibitory Abs (>75th percentile) had a 66% reduction in the risk of blood-stage infection relative to others in the population (95% confidence interval, 3–88%). In contrast, high levels of MSP-119 IgG or IgG subclass Abs measured by enzyme immunoassay with six different recombinant MSP-119 Ags did not correlate with protection from infection. IgG Abs measured by serology and functional invasion-inhibitory activity did not correlate with each other. These findings implicate an important protective role for MSP-119-specific invasion inhibitory Abs in immunity to blood-stage P. falciparum infection, and suggest that the measurement of MSP-119 specific inhibitory Abs may serve as an accurate correlate of protection in clinical trials of MSP-1-based vaccines.Keywords
This publication has 43 references indexed in Scilit:
- A New Rodent Model to Assess Blood Stage Immunity to the Plasmodium falciparum Antigen Merozoite Surface Protein 119 Reveals a Protective Role for Invasion Inhibitory AntibodiesJournal of Experimental Medicine, 2003
- Merozoite Surface Protein 1-Specific Immune Response Is Protective against Exoerythrocytic Forms ofPlasmodium yoeliiInfection and Immunity, 2002
- Towards a blood-stage vaccine for malaria: are we following all the leads?Nature Reviews Immunology, 2001
- Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum11Edited by J. A. WellsJournal of Molecular Biology, 2001
- Cytokine Responses toPlasmodium falciparumLiver-Stage Antigen 1 Vary in Rainy and Dry Seasons in Highland KenyaInfection and Immunity, 2000
- Anti–Merozoite Surface Protein–1 19‐kDa IgG in Mother‐Infant Pairs Naturally Exposed toPlasmodium falciparum:Subclass Analysis with Age, Exposure to Asexual Parasitemia, and Protection against Malaria. V. The Asembo Bay Cohort ProjectThe Journal of Infectious Diseases, 2000
- New insights into the epidemiology of malaria relevant for disease controlBritish Medical Bulletin, 1998
- Antibodies that Inhibit Malaria Merozoite Surface Protein–1 Processing and Erythrocyte Invasion Are Blocked by Naturally Acquired Human AntibodiesJournal of Experimental Medicine, 1997
- Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.Journal of Experimental Medicine, 1994
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988